Anthrocell Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 1

Anthrocell General Information

Description

Operator of a biotechnology company intended to develop novel biopharmaceutical drugs for human immune system. The company's platform gives monoclonal antibody products for oncology applications and produce biopharmaceutical proteins, enabling patients to get cured of cancer and age-related diseases.

Contact Information

Website
www.anthrocell.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • National Innovation Centre Australian Technology Park
  • Suite G15, 4 Cornwallis Street
  • Eveleigh, New South Wales 2015
  • Australia
+61 (02) 0000 0000
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • National Innovation Centre Australian Technology Park
  • Suite G15, 4 Cornwallis Street
  • Eveleigh, New South Wales 2015
  • Australia
+61 (02) 0000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Anthrocell Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator Completed Startup
To view Anthrocell’s complete valuation and funding history, request access »

Anthrocell Executive Team (3)

Name Title Board Seat
Galina Kaseko Co-Founder, Chief Executive Officer & Board Member
Tohsak Mahaworasilpa Ph.D Co-Founder, Chief Scientific Officer & Board Member
Eli Tal Executive Chairman
To view Anthrocell’s complete executive team members history, request access »

Anthrocell Board Members (4)

Name Representing Role Since
Eli Tal Anthrocell Executive Chairman 000 0000
Nicholas Weininger Self Board Member 000 0000
Suwit Khunkitti Ph.D Self Board Member 000 0000
Tohsak Mahaworasilpa Ph.D Anthrocell Co-Founder, Chief Scientific Officer & Board Member 000 0000
To view Anthrocell’s complete board members history, request access »

Anthrocell Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Anthrocell Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Cicada Innovations Accelerator/Incubator Minority 000 0000 000000 0
To view Anthrocell’s complete investors history, request access »

Ready to get started?

Request a free trial

Anthrocell FAQs

  • When was Anthrocell founded?

    Anthrocell was founded in 2010.

  • Who is the founder of Anthrocell?

    Galina Kaseko and Tohsak Mahaworasilpa Ph.D are the founders of Anthrocell.

  • Who is the CEO of Anthrocell?

    Galina Kaseko is the CEO of Anthrocell.

  • Where is Anthrocell headquartered?

    Anthrocell is headquartered in Eveleigh, Australia.

  • What is the size of Anthrocell?

    Anthrocell has 6 total employees.

  • What industry is Anthrocell in?

    Anthrocell’s primary industry is Drug Discovery.

  • Is Anthrocell a private or public company?

    Anthrocell is a Private company.

  • What is Anthrocell’s current revenue?

    The current revenue for Anthrocell is 000000.

  • Who are Anthrocell’s investors?

    Cicada Innovations has invested in Anthrocell.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »